Treatment Dilemma in Children with Late-Onset Pompe Disease.
Ontology highlight
ABSTRACT: In recent years, there has been a significant increase in the diagnosis of asymptomatic Late-Onset Pompe Disease (LOPD) patients, who are detected via family screening or Newborn Screening (NBS). The dilemma is when to start Enzyme Replacement Therapy (ERT) in patients without any clinical sign of the disease, considering its important benefits in terms of loss of muscle but also its very high cost, risk of side effects, and long-term immunogenicity. Muscle Magnetic Resonance Imaging (MRI) is accessible, radiation-free, and reproducible; therefore, it is an important instrument for the diagnosis and follow-up of patients with LOPD, especially in asymptomatic cases. European guidelines suggest monitoring in asymptomatic LOPD cases with minimal MRI findings, although other guidelines conside
SUBMITTER: Faraguna MC
PROVIDER: S-EPMC9957524 | biostudies-literature | 2023 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA